Welcome to our dedicated page for My Size SEC filings (Ticker: MYSZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for My Size, Inc. (NASDAQ: MYSZ), an AI-powered fashion technology and retail solutions company. Through these documents, investors can review how MySize reports its financial condition, governance decisions, and material events related to its global fashion-tech platform.
MySize’s recent SEC activity includes Form 8-K current reports that reference press releases on quarterly financial results and other significant developments. For example, the company has filed 8-Ks to furnish results for periods such as the second and third quarters of 2025, incorporating earnings press releases as exhibits. Another 8-K details the outcomes of its annual meeting of stockholders, including votes on director elections and amendments to the My Size, Inc. 2017 Equity Incentive Plan.
The DEF 14A definitive proxy statement offers additional insight into MySize’s corporate governance. It outlines proposals presented at the annual meeting, such as increasing the share reserve under the equity incentive plan, adopting an evergreen provision for future share increases, and ratifying the appointment of the company’s independent public accountant. The proxy materials also explain how the annual meeting is conducted and how shareholders may vote.
On Stock Titan, MySize’s filings are updated as they are posted to the SEC’s EDGAR system. AI-powered summaries help explain the key points of lengthy documents, making it easier to understand topics such as results of operations, equity plan changes, and voting outcomes. Users can review current reports on Form 8-K, proxy statements like the DEF 14A, and other filings to track MySize’s regulatory history, governance decisions, and disclosures tied to its AI-driven fashion and retail platform.
My Size, Inc. reported that Nasdaq notified the company its common stock closed below $1.00 for 30 consecutive trading days, triggering a minimum bid price deficiency. The company has 180 days, until August 31, 2026, to regain compliance by maintaining a closing bid of at least $1.00 for 10 consecutive business days.
The company said the notice does not affect its current operations, customers, financial position, or the continued trading of its shares on Nasdaq under the symbol MYSZ. Management reiterated a focus on execution, revenue quality, and higher-margin activities. My Size generated approximately $10 million of revenue in 2025, with its Orgad business operating at about 40% gross margin, and its 10peaks subsidiary generating roughly $150,000 of revenue at about 65% gross margin before operating expenses. Management currently estimates 10peaks could reach around $3 million in annual revenue based on current commercial assumptions.
My Size, Inc. received a notice from Nasdaq that its stock no longer meets the minimum bid price requirement of $1.00 per share for continued listing on the Nasdaq Capital Market. This follows 30 consecutive business days with a closing bid price below that level.
The company has 180 calendar days, until August 31, 2026, to regain compliance by achieving a closing bid of at least $1.00 for 10 consecutive business days. If it still does not comply, it may qualify for an additional 180-day period if it meets other Nasdaq listing standards.
If compliance is not regained, Nasdaq may move to delist the shares, though My Size would have the right to appeal. The company plans to monitor its share price and is considering options such as a potential reverse stock split to restore compliance.
My Size, Inc. reported that its Chief Executive Officer and director, Ronen Luzon, received grants of restricted common stock under the company’s 2017 Equity Incentive Plan on December 15, 2025. He was granted 215,000 restricted shares at a price of $0, bringing his directly held beneficial ownership to 289,335 shares after the transaction. These awards include time-based vesting in three equal annual installments from January 1, 2026 through January 1, 2028, a tranche vesting on December 31, 2025, and performance-based vesting tied to profit and business targets, all subject to continued service.
Luzon also reported indirect ownership through his spouse, Chief Product Officer and Chief Operating Officer Billy Pardo. She received 60,000 restricted shares at a price of $0, increasing the indirectly beneficially owned common stock to 79,750 shares. Her awards follow similar time-based and performance-based vesting schedules under the same plan, conditioned on her continued service to My Size and achievement of specified business and profit targets.
My Size, Inc. reported an insider equity grant to director Oron Branitzky. On December 15, 2025, he received 15,000 shares of common stock as restricted shares under the My Size, Inc. 2017 Equity Incentive Plan at a stated price of $0 per share. Following this award, he beneficially owns 17,500 common shares directly.
The restricted shares are scheduled to vest on December 31, 2025, provided Branitzky continues to serve the company through that date. This filing reflects equity-based compensation rather than an open-market purchase or sale.
My Size, Inc. reported that its Chief Financial Officer received a new equity award. On December 15, 2025, the CFO acquired 30,000 shares of common stock as restricted stock under the company’s 2017 Equity Incentive Plan at a stated price of $0 per share. Following this grant, the officer beneficially owns 32,500 shares directly.
The restricted shares vest in three equal annual installments, with one-third vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, as long as the officer continues to serve the company through each vesting date.
My Size, Inc. reported that Chief Growth Officer Borja Cembrero received an award of 110,000 shares of common stock as restricted stock on December 15, 2025 under the company’s 2017 Equity Incentive Plan. The shares were acquired at a stated price of $0, and his beneficial ownership after the grant is 117,965 shares, held directly.
Of the award, 10,000 restricted shares vest immediately, while 40,000 restricted shares vest in three equal annual installments on January 1, 2026, 2027, and 2028, subject to continued service. Up to 60,000 additional restricted shares may vest if specified profit and business targets in the restricted stock agreement are achieved and Cembrero remains in service through the applicable vesting dates.
My Size, Inc. reported that a director received a grant of restricted common stock. On 12/15/2025, the director acquired 15,000 shares of My Size common stock at a stated price of $0 per share under the company’s 2017 Equity Incentive Plan. Following this grant, the director beneficially owns 17,500 shares of common stock in direct ownership form.
The filing explains that these 15,000 restricted shares will vest on December 31, 2025, provided the director continues to serve the company through that vesting date.
My Size, Inc. executive Billy Pardo, the company’s CPO and COO, reported receiving restricted common stock awards on December 15, 2025 under the My Size, Inc. 2017 Equity Incentive Plan. He acquired 60,000 restricted shares at a price of $0, bringing his direct beneficial ownership to 79,750 shares.
In addition, Pardo reports indirect beneficial ownership of 215,000 restricted shares held by his spouse, director and CEO Ronen Luzon, increasing indirect holdings to 289,335 shares. Portions of these awards vest annually on January 1, 2026, 2027 and 2028, with other tranches tied to profit and business targets and a separate block vesting on December 31, 2025, all contingent on continued service.
My Size, Inc. director Roy Golan reported an equity award from the company. On 12/15/2025, he was granted 15,000 shares of common stock at a price of $0, reported as an acquisition of securities. Following this grant, he beneficially owns 15,000 shares, held directly.
The filing explains that these are restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan. The restricted shares are scheduled to vest on December 31, 2025, and vesting is conditioned on Golan’s continued service to My Size, Inc. as of that vesting date.
My Size, Inc. director Arik Kaufman received 15,000 restricted shares of common stock on December 15, 2025. The shares were granted at a price of $0 under the My Size, Inc. 2017 Equity Incentive Plan as part of his director compensation.
These restricted shares are scheduled to vest on December 31, 2025, provided he continues to serve the company through that date. Following this grant, Kaufman beneficially owns 17,500 shares of My Size, Inc. common stock in direct ownership.